bpc 157 nasal spray vs injection bpc-157 intranasal administration study BPC-157 vs. Injections Curious about which form of
Description
Research consistently shows low toxicity, minimal immunogenicity, and no significant adverse effects in controlled experimental conditions, supporting its suitability for scientific investigation rather than therapeutic application
Patient Characteristics Most patients in cohort 1 were female (62.2%), and the mean age was 70.4 years (standard deviation [SD],13.2)

I sent an email with a question about my order and still no response

Product label: CYANOKIT (hydroxocobalamin) injection, powder, lyophilized, for solution [Meridian Medical Technologies, Inc.] Last revised: April 2011 [DailyMed] The cobalt ion in hydroxocobalamin combines with cyanide to form the nontoxic cyanocobalamin
